Raw frequency data specifying the number and percentage of COVID-19 patients that experienced discernible symptoms from clinical datasets from China [20] and USA [17].

These frequencies were used to simulate patients to find the likeliest paths of symptom onset for discernible symptoms of COVID-19. The dataset from China contains 55,924 patients, and the dataset from USA contains 373,883 patients. (XLSX)